ESTABLISHING THERAPEUTIC EQUIVALENCY - WHAT IS A CLINICALLY SIGNIFICANT DIFFERENCE

被引：10

作者：

DETSKY, AS

SACKETT, DL

机构：

来源：

ARCHIVES OF INTERNAL MEDICINE | 1986年 / 146卷 / 05期

关键词：

D O I：

10.1001/archinte.146.5.861

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：861 / 862

页数：2

相关论文

共 4 条

[1] USING ECONOMIC-ANALYSIS TO DETERMINE THE RESOURCE CONSEQUENCES OF CHOICES MADE IN PLANNING CLINICAL-TRIALS
DETSKY, AS
[J]. JOURNAL OF CHRONIC DISEASES, 1985, 38 (09): : 753 - 765
[2] WHEN WAS A NEGATIVE CLINICAL-TRIAL BIG ENOUGH - HOW MANY PATIENTS YOU NEEDED DEPENDS ON WHAT YOU FOUND
DETSKY, AS
SACKETT, DL
[J]. ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (04) : 709 - 712
[3] IMPORTANCE OF BETA, TYPE-II ERROR AND SAMPLE-SIZE IN DESIGN AND INTERPRETATION OF RANDOMIZED CONTROL TRIAL - SURVEY OF 71 NEGATIVE TRIALS
FREIMAN, JA
CHALMERS, TC
SMITH, H
KUEBLER, RR
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (13) : 690 - 694
[4] SOME ISSUES IN THE DESIGN AND INTERPRETATION OF NEGATIVE CLINICAL-STUDIES
MAKUCH, RW
JOHNSON, MF
[J]. ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (05) : 986 - 989